中寵股份(002891.SZ)旗下雲吸貓智能獲得債務豁免 本息合計828.606萬元
格隆匯12月13日丨中寵股份(002891.SZ)公佈,2018年12月27日,公司下屬子公司南京雲吸貓智能科技有限公司(債務人,“雲吸貓智能”)與滁州雲寵智能科技有限公司(債權人,“雲寵智能”)簽訂《借款合同》,約定由雲寵智能向雲吸貓智能出借款項人民幣800萬元用於雲吸貓智能的日常運營。
2019年12月13日,公司召開了第二屆董事會第二十七次會議,審議並通過了《關於全資子公司獲得債務豁免暨關聯交易的議案》,並由雲吸貓智能與雲寵智能簽訂了《放棄債權聲明》,約定雲寵智能放棄對雲吸貓智能的前述債權權利,本息合計人民幣828.606萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.